Wegovy® is an FDA-approved prescription medication for chronic weight management in adults who meet specific BMI criteria. It contains semaglutide, a GLP-1 receptor agonist that helps regulate appetite and food intake through the brain–gut connection, supporting sustainable, clinically proven weight loss over time.
Zepbound® is an FDA-approved prescription medication for chronic weight management in adults who meet specific BMI and metabolic health criteria. It contains tirzepatide, a next-generation therapy that activates both GLP-1 and GIP receptors, two key pathways involved in appetite regulation, blood sugar control, and metabolic efficiency.
Wegovy® is an FDA-approved prescription medication for chronic weight management in adults who meet specific BMI criteria. It contains semaglutide, a GLP-1 receptor agonist that helps regulate appetite and food intake through the brain–gut connection, supporting sustainable, clinically proven weight loss over time.
Foundayo® is a prescription medicine used with a reduced-calorie diet and increased physical activity to help adults with obesity, or some adults with overweight who also have weight-related medical problems, to lose excess body weight and keep the weight off.
*Image for illustration only. Medications referenced are branded products and are dispensed by licensed pharmacies. Avara Rx is not a state-licensed pharmacy or a drug manufacturer. All prescriptions are provided only when clinically appropriate following an evaluation by a licensed healthcare provider. Branded medications are approved by the FDA for safety, efficacy, and quality; however, individual results may vary. Your provider will work with you to determine the most appropriate treatment for your specific healthcare needs.
Wegovy vs Zepbound
| Features |  Wegovy® |  Zepbound® |
|---|---|---|
| Drug class | GLP-1 agonist | GIP + GLP-1 dual agonist |
| Avg. weight loss | ~15% body weight | ~20–22.5% body weight |
| Dosing schedule | Once weekly | Once weekly |
| Max dose | 2.4 mg | 15 mg |
| FDA approval year | 2021 | 2023 |
| Cardiovascular benefit | ✓ | ✓ |
| Insurance coverage | Broader coverage | Growing coverage |
| Starting price | Starts at $149/mo Consultation | Starts at $149/mo Consultation |
Enter your height and weight below to calculate your BMI.
